The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Open accessAbstract
Two cannabinoid receptors have been identified: CB 1 , present in the central nervous system (CNS) and to a lesser extent in other tissues, and CB 2 , present outside the CNS, in peripheral organs. There is evidence for the presence of CB 2 -like receptors in peripheral nerve terminals. We report now that we have synthesized a CB 2 -specific agonist, code-named HU-308. This cannabinoid does not bind to CB 1 ( K i > 10 μM), but does so efficiently to CB 2 ( K i = 22.7 ± 3.9 nM); it inhibits forskolin-stimulated cyclic AMP production in CB 2 -transfected cells, but does so much less in CB 1 -transfected cells. HU-308 shows no activity in mice in a tetrad of behavioral tests, which together have been shown to be specific for tetrahydrocannabinol (THC)-type activity in the CNS mediated by CB 1 . However, HU-308 reduces blood pressure, blocks defecation, and elicits anti-inflammatory and peripheral analgesic activity. The hypotension, the inhibition of defecation, the anti-inflammatory and peripheral analgesic effects produced by HU-308 are blocked (or partially blocked) by the CB 2 antagonist SR-144528, but not by the CB 1 antagonist SR-141716A. These results demonstrate the feasibility of discovering novel nonpsychotropic cannabinoids that may lead to new therapies for hypertension, inflammation, and pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Self-citationMolecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Self-citationThe formalin test: an evaluation of the method
Tjølsen, A., Berge, O.-G., Hunskaar, S., Rosland, J. H., & Hole, K. (1992) · Pain · doi:10.1016/0304-3959(92)90003-t · Cited by 2,428
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Self-citationCannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Self-citationIncreased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Fride, E., & Mechoulam, R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90468-w · Cited by 451
Self-citationMechoulam, R., Fride, E., & Di Marzo, V. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 428
Self-citationVarga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1035 · Cited by 410
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
Martin, B. R., Compton, D. R., Thomas, B. F., Prescott, W. R., Little, P. J., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R., & Susan J., W. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90349-7 · Cited by 409
Self-citationRoss, R. A., Brockie, H. C., Stevenson, L. A., Murphy, V. L., Templeton, F., Makriyannis, A., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702351 · Cited by 404
Self-citationJaggar, S. I., Hasnie, F. S., Sellaturay, S., & Rice, A. S. C. (1998) · Pain · doi:10.1016/s0304-3959(98)00041-4 · Cited by 354
Cannabinoids as Therapeutic Agents
(2019) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429260667 · Cited by 311
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R., & Kunos, G. (1997) · Nature · doi:10.1038/37371 · Cited by 284
Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
Wagner, J. A., Varga, K., Járai, Z., & Kunos, G. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.429 · Cited by 257
A novel probe for the cannabinoid receptor
Devane, W. A., Breuer, A., Sheskin, T., Jaerbe, T. U. C., Eisen, M. S., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a018 · Cited by 205
Self-citationThe Functional Neuroanatomy of Brain Cannabinoid Receptors
Breivogel, C. S., & Childers, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0229 · Cited by 197
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake, K. D., Compton, D. M., Varga, K., Martin, B. R., & Kunos, G. (1997) · PubMed · Cited by 195
New hot plate tests to quantify antinociceptive and narcotic antagonist activities
Ankier, S. I. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90195-2 · Cited by 177
Huffman, J. W., Yu, S., Showalter, V., Abood, M. E., Wiley, J. L., Compton, D. R., Martin, B. R., Bramblett, R. D., & Reggio, P. H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960394y · Cited by 173
Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals
Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L. J., Shire, D., Huffman, J. W., Yu, S., Lainton, J. A. H., & Pertwee, R. G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01336-8 · Cited by 171
Self-citationMechoulam, R., Lander, N., & Zahalka, J. (1990) · Tetrahedron Asymmetry · doi:10.1016/s0957-4166(00)86322-3 · Cited by 121
Self-citationCardiovascular actions of cannabinoids and their generation during shock
Wagner, J. A., Varga, K. R., & Kunos, G. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050287 · Cited by 111
Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors
Gareau, Y., Dufresne, C., Gallant, M., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., WEECH, P. K., Metters, K. M., & Labelle, M. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00573-c · Cited by 110
Mechoulam, R., Fride, E., Ben‐Shabat, S., Meiri, U., & Horowitz, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00777-8 · Cited by 107
Self-citationNew class of potent ligands for the human peripheral cannabinoid receptor
Gallant, M., Dufresne, C., Gareau, Y., Guay, D., Leblanc, Y., Prasit, P., Rochette, C., Sawyer, N., Slipetz, D. M., Tremblay, N. M., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00426-x · Cited by 101
Δ9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
Krowicki, Z. K., Moerschbaecher, J. M., Winsauer, P. J., Sivarao, D. V., & Hornby, P. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00165-x · Cited by 94
Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
Shook, J. E., & Burks, T. F. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23416-4 · Cited by 93
Pertwee, R. G. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00282-9 · Cited by 84
Self-citationInhibition of intestinal motility by anandamide, an endogenous cannabinoid.
Calignano, A., La Rana, G., Makriyannis, A., et al. (1997) · PubMed · Cited by 79
The CB1Cannabinoid Receptor in the Brain
Howlett, A. C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0215 · Cited by 79
Cannabinoid Receptors and Their Endogenous Agonist, Anandamide
Axelrod, J., & Felder, C. C. (1998) · Neurochemical Research · doi:10.1023/a:1022418217479 · Cited by 72
Anandamides: tolerance and cross-tolerance toΔ9-tetrahydrocannabinol
Fride, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00790-w · Cited by 67
Self-citationRoss, R. A., Gibson, T. M., Stevenson, L., Saha, B., Crocker, P. J., Razdan, R. K., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702836 · Cited by 58
Self-citationCannabinoid receptor agonists and antagonists
Barth, F. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.3.301 · Cited by 52
The Pharmacology of SR 141716A: A Review
Nakamura-Palacios, E. M., Moerschbaecher, J. M., & Barker, L. A. (1999) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1999.tb00085.x · Cited by 21
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…activity of cannabinoids in models of acute and chronic, neuropathic pain, especially of inflammatory origin (Calignano et al., 1998; Hanus et al., 1999; Malan et al., 2001; Clayton et al., 2002; Ibrahim et al., 2003, 2005; Nackley et al., 2003a,b, 2004; Quartilho et al., 2003;…”
BackgroundTaming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Self-citationThe endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Metadata
- Authors
- Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-12-07
- Volume
- 96
- Issue
- 25
- Pages
- 14228-14233
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2082237701
- Cited by
- 571
- References
- 42
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.